Ensysce Biosciences (ENSCW) Income towards Parent Company (2018 - 2025)

Ensysce Biosciences (ENSCW) has 8 years of Income towards Parent Company data on file, last reported at -$3.7 million in Q3 2025.

• Income towards Parent Company for Q3 2025 came in at -$3.7 million, down 684.92% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.5 million (up 6.73% YoY), and the FY2024 annual result was -$8.0 million, up 27.64% from the prior year.
• Income towards Parent Company eased to -$3.7 million in Q3 2025 per ENSCW's latest filing, from -$1.8 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $640683.0 in Q3 2024 and troughed at -$16.9 million in Q3 2021.
• A 5-year average of -$3.8 million and a median of -$2.7 million in 2023 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2021 and 2024: Income towards Parent Company slumped 2623.52% in 2021, then soared 123.6% in 2024.
• A 5-year view of Income towards Parent Company shows it stood at -$2.0 million in 2021, then sank by 207.24% to -$6.2 million in 2022, then soared by 43.58% to -$3.5 million in 2023, then declined by 2.23% to -$3.6 million in 2024, then slipped by 4.73% to -$3.7 million in 2025.
• Business Quant data shows ENSCW's Income towards Parent Company at -$3.7 million in Q3 2025, -$1.8 million in Q2 2025, and -$2.0 million in Q1 2025.